Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chemotherapy-induced peripheral neuropathy.

P H Hilkens1, M J ven den Bent

  • 1Department of Neurology, Rijnstate Hospital Arnhem, Dr. Daniel den Hoed Cancer Center Rotterdam, The Netherlands.

Journal of the Peripheral Nervous System : JPNS
|January 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical course and risk factors of neurotoxicity following cisplatin in an intensive dosing schedule.

European journal of neurology·2013
Same author

Intramedullary enterogenous cyst presenting with spastic paraparesis during two consecutive pregnancies: a case report.

Journal of neurology, neurosurgery, and psychiatry·2001
Same author

Corticosteroid co-medication does not reduce the incidence and severity of neurotoxicity induced by docetaxel.

Anti-cancer drugs·1998
Same author

Lhermitte's sign following chemotherapy with docetaxel.

Neurology·1998
Same author

Phase I and pharmacologic study of docetaxel and cisplatin in patients with advanced solid tumors.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·1997
Same author

Clinical characteristics of severe peripheral neuropathy induced by docetaxel (Taxotere).

Annals of oncology : official journal of the European Society for Medical Oncology·1997

Chemotherapy drugs like cisplatin can cause peripheral neurotoxicity, leading to disabling symptoms. This review details these neuropathies and discusses potential neuroprotective agents, though more research is needed.

Area of Science:

  • Oncology
  • Neuroscience
  • Pharmacology

Background:

  • Peripheral neurotoxicity is a significant side effect of numerous chemotherapeutic agents.
  • This neuropathy, often axonal, can result in severe and debilitating symptoms, impacting treatment efficacy.
  • The use of neurotoxic drug combinations, such as cisplatin/paclitaxel, highlights the clinical importance of managing neurotoxicity.

Purpose of the Study:

  • To review the pathogenesis, clinical presentation, and neurophysiologic findings of chemotherapy-induced peripheral neurotoxicity.
  • To examine the relationship between drug dosage and neuropathy for key cytostatic drugs.
  • To discuss potential neuroprotective agents and the need for further clinical validation.

Main Methods:

  • Literature review of chemotherapy-induced peripheral neurotoxicity.

Related Experiment Videos

  • Analysis of data on cisplatin, vincristine, paclitaxel, docetaxel, and suramin.
  • Discussion of neurophysiologic findings and nerve biopsy results.

    • Main Results:

    • Peripheral neurotoxicity is a common and dose-limiting side effect of specific chemotherapeutic agents.
    • The severity of neuropathy is often related to cumulative dosage and dosage per cycle.
    • Potential neuroprotective agents like nerve growth factors show promise but require more clinical data.

    Conclusions:

    • Understanding chemotherapy-induced neurotoxicity is crucial for effective patient management.
    • Current neuroprotective agents have limited clinical data, necessitating further trials.
    • Preventing or delaying neurotoxicity could enhance the effectiveness of cancer treatment regimens.